| dc.contributor.author | Mansoor Lakooraj, Hamed | en_US |
| dc.contributor.author | Khaki, Zohreh | en_US |
| dc.contributor.author | Ghorbani, Masoud | en_US |
| dc.contributor.author | Shafiee Ardestani, Mehdi | en_US |
| dc.contributor.author | Dezfoulian, Omid | en_US |
| dc.date.accessioned | 1399-07-09T06:39:01Z | fa_IR |
| dc.date.accessioned | 2020-09-30T06:39:01Z | |
| dc.date.available | 1399-07-09T06:39:01Z | fa_IR |
| dc.date.available | 2020-09-30T06:39:01Z | |
| dc.date.issued | 2020-06-01 | en_US |
| dc.date.issued | 1399-03-12 | fa_IR |
| dc.date.submitted | 2019-11-09 | en_US |
| dc.date.submitted | 1398-08-18 | fa_IR |
| dc.identifier.citation | Mansoor Lakooraj, Hamed, Khaki, Zohreh, Ghorbani, Masoud, Shafiee Ardestani, Mehdi, Dezfoulian, Omid. (2020). The in vitro Effect of Doxorubicine-G2-FA Treatment on Breast Cancer Copyright. Iranian Journal of Veterinary Medicine, 14(2), 147-158. doi: 10.22059/ijvm.2019.291998.1005039 | en_US |
| dc.identifier.issn | 2251-8894 | |
| dc.identifier.issn | 2252-0554 | |
| dc.identifier.uri | https://dx.doi.org/10.22059/ijvm.2019.291998.1005039 | |
| dc.identifier.uri | https://ijvm.ut.ac.ir/article_76816.html | |
| dc.identifier.uri | https://iranjournals.nlai.ir/handle/123456789/306582 | |
| dc.description.abstract | BACKGROUND:<br /> <span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA"><span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA">To achieve delivery of a drug to tumors, folic acid (FA) was used as a targeting ligand to</span></span><br /> change nanocarriers. Since the folate receptor has more expression in several tumor types such as breast cancer.<br /> OBJECTIVES:<br /> <span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA"><span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA">The present study aimed to evaluate the effect of Doxorubicine-G2-FA (Dox- G2-FA) with</span></span><br /> in vitro assays. The abbreviation of G2 represents the second generation of dendrimer synthesis.<br /> METHODS:<br /> <span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA"><span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA">For this purpose, Dox-G2-FA was synthesized and mass spectroscopy was used to confirm the</span></span><br /> synthesized component. Also, MTT assay, flow cytometry, and gene expression assay by real-time PCR were<br /> used to evaluate cell viability, apoptosis, and necrosis.<br /> RESULTS:<br /> <span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA"><span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA">In this study, the effect of Dox and Dox-G2-FA on the expression of Bax, Bcl2 genes showed</span></span><br /> that there was a significant decrease in the expression of the Bcl2 gene in the Dox-G2-FA group compared to<br /> Dox and control groups(<br /> <br /> <em><span style="font-family: TimesNewRomanPS-ItalicMT; font-size: medium;"><span style="font-family: TimesNewRomanPS-ItalicMT; font-size: medium;">P</span></span></em><span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA"><span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA"><0.05). Also, the results of flow-cytometry showed that apoptosis in the presence of</span></span><br /> Dox-G2-FA was greater than in the Dox group (<br /> <br /> <em><span style="font-family: TimesNewRomanPS-ItalicMT; font-size: medium;"><span style="font-family: TimesNewRomanPS-ItalicMT; font-size: medium;">P</span></span></em><span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA"><span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA"><0.05).</span></span><br /> CONCLUSIONS:<br /> <span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA"><span style="font-family: TimesNewRomanPSMT; font-size: medium;" lang="JA">Therefore, it seems that the effect of Dox-G2-FA on apoptosis is better than the effect of</span></span><br /> Dox usage alone. | en_US |
| dc.format.extent | 702 | |
| dc.format.mimetype | application/pdf | |
| dc.language | English | |
| dc.language.iso | en_US | |
| dc.publisher | University of Tehran | en_US |
| dc.publisher | دانشگاه تهران | fa_IR |
| dc.relation.ispartof | Iranian Journal of Veterinary Medicine | en_US |
| dc.relation.ispartof | مجله طب دامی ایران | fa_IR |
| dc.relation.isversionof | https://dx.doi.org/10.22059/ijvm.2019.291998.1005039 | |
| dc.subject | Apoptosis | en_US |
| dc.subject | Bax | en_US |
| dc.subject | Bcl2 | en_US |
| dc.subject | Breast Cancer | en_US |
| dc.subject | Doxorubicine-G2-folate | en_US |
| dc.title | The in vitro Effect of Doxorubicine-G2-FA Treatment on Breast Cancer Copyright | en_US |
| dc.type | Text | en_US |
| dc.type | Clinical Pathology | en_US |
| dc.contributor.department | 1Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran | en_US |
| dc.contributor.department | Department of Clinical Pathology, Faculty of Veterinary Medicine, University of Tehran, Tehran, Iran | en_US |
| dc.contributor.department | Pasteur Institute of Iran, Research and Production Complex, Department of Research and Development | en_US |
| dc.contributor.department | 3Department of Radiopharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran | en_US |
| dc.contributor.department | 4Department of Pathobiology, Faculty of Veterinary Medicine, Lorestan University, Khorramabad, Iran | en_US |
| dc.citation.volume | 14 | |
| dc.citation.issue | 2 | |
| dc.citation.spage | 147 | |
| dc.citation.epage | 158 | |